Effect of Health Belief Model-Based Education on Cervical Cancer Knowledge and HPV Vaccine Attitudes in Women

NCT07521163 | Not Yet Recruiting

• 2 other identifiers: 09.03.2026-238631EA-2026-5244
• Study Type: interventional
• Target: 100
• Locations: 0 countries
• Sites: N/A

Brief Summary

This study aims to evaluate the effect of a Health Belief Model-based educational intervention on women's knowledge of cervical cancer and their attitudes and beliefs toward HPV vaccination. The study will be conducted among women aged 18-49 years attending a primary health care center in Van, Turkey. Participants will be assigned to intervention and control groups. The intervention group will receive a structured, face-to-face educational program, while the control group will receive routine care. Data will be collected using validated questionnaires before and after the intervention. The findings are expected to contribute to improving preventive health behaviors and increasing HPV vaccination awareness among women.

Conditions

Cervical Cancer; Preventive Health Services; Human Papillomavirus Infection

Keywords

Health Belief Model; HPV Vaccination; Cervical Cancer Screening; Health Education; Primary Health Care; Women's Health

Outcome Measures

Primary Outcomes (2)

• Change in Cervical Cancer Knowledge Score

  Change in participants' knowledge of cervical cancer was assessed using the Cervical Cancer Knowledge Scale. The scale consists of 20 items, with total scores ranging from 0 to 20, where higher scores indicate greater knowledge about cervical cancer. Measurements were conducted before the educational intervention and 15 days after the intervention.

  Baseline and 15 days post-intervention

• Change in HPV Vaccination Attitudes and Beliefs Score

  Change in participants' attitudes and beliefs toward HPV vaccination was assessed using the Carolina HPV Immunization Attitudes and Beliefs Scale (CHIAS). The scale consists of 16 items rated on a 4-point Likert scale, with total scores ranging from 16 to 64, where higher scores indicate more negative attitudes and beliefs toward HPV vaccination. Measurements were conducted before the intervention and 15 days after the intervention.

  Baseline and 15 days post-intervention

Study Arms (2)

Experimental

EXPERIMENTAL

Participants will receive a Health Belief Model-based structured face-to-face educational program consisting of two sessions.

Behavioral: Health Belief Model-Based Education

No Intervention

NO INTERVENTION

Participants will receive routine primary health care services without additional structured education.

Interventions

Health Belief Model-Based Education BEHAVIORAL

A structured face-to-face educational program on cervical cancer, HPV infection, screening, HPV vaccination, and common misconceptions based on the Health Belief Model.

Experimental

Eligibility Criteria

• Age: 18 Years - 49 Years
• Sex: female
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• Women aged 18-49 years
• Attending the Tusba Training Family Health Center
• Able to read and write Turkish
• Willing to participate in the study
• Provided written informed consent

You may not qualify if:

• Having received HPV vaccination previously
• History of cervical cancer
• Presence of severe psychiatric, cognitive, or communication disorders
• Inability to attend the educational sessions

Sponsors & Collaborators

• Muhammet Faruk Yigit: lead

Related Publications (2)

• Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr. 2014 Jan;168(1):76-82. doi: 10.1001/jamapediatrics.2013.2752.

  PMID: 24276343 RESULT

• Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med. 2007 Aug-Sep;45(2-3):107-14. doi: 10.1016/j.ypmed.2007.05.013. Epub 2007 Jun 2.

  PMID: 17628649 RESULT

MeSH Terms

Conditions

Uterine Cervical Neoplasms; Papillomavirus Infections; Health Education

Condition Hierarchy (Ancestors)

Uterine Neoplasms; Genital Neoplasms, Female; Urogenital Neoplasms; Neoplasms by Site; Neoplasms; Uterine Cervical Diseases; Uterine Diseases; Genital Diseases, Female; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Genital Diseases; Sexually Transmitted Diseases, Viral; Sexually Transmitted Diseases; Communicable Diseases; Infections; DNA Virus Infections; Virus Diseases; Tumor Virus Infections; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Adherence Interventions; Medication Adherence; Patient Compliance; Patient Acceptance of Health Care; Treatment Adherence and Compliance; Health Behavior; Behavior

Central Study Contacts

Muhammet Faruk Yiğit, PhD

CONTACT

+90 542 424 76 29; muhammed-1466@hotmail.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: PhD of Health Sciences

Study Record Dates

• First Submitted: April 2, 2026
• First Posted: April 9, 2026
• Study Start: April 20, 2026
• Primary Completion: May 25, 2026
• Study Completion (Estimated): June 30, 2026
• Last Updated: April 15, 2026

Record last verified: 2026-04

Data Sharing

• IPD Sharing: Will not share